Catherine Skari

Juggling Between The Cost And Value of New Therapies: Does Science Still Serve Patient Needs?

In the aftermath of the withdrawal of Zynteglo, the first gene therapy for patients with β-thalassaemia, from Europe, TIF´s Executive…

Read More »

Coming Up This Thursday: Discussion On Access To Innovative Therapies – The Reblozyl Case

After receiving numerous questions from patients regarding the innovative treatment for β-thalassaemia Reblozyl (luspatercept), approved for use in the US,…

Read More »

UK & Wales: NICE Recommends First Treatment In Two Decades For Sickle Cell Disease

For the first time in 20 years, a new therapy for sickle cell disease is to be made available on…

Read More »

WEBINAR 3: Communication Skills – Focusing on Social Media by Dr. Barry Connolly

Read More »

WEBINAR 3: Communication Skills – How, When & Whom to Write by Craig Butler

Read More »

WEBINAR 2: Examples & Practical Skills for Advocacy Strategy Implementation by George Constantinou

Read More »

WEBINAR 2: Effective Advocacy & Lobbying for Non-Profits by Loris Brunetta

Read More »

WEBINAR 1: Strategy & Planning – Putting Theory Into Practice by Lily Cannon

Read More »

WEBINAR 1: The Perfect Example of an Association’s Strategic Plan by Riyad Elbard

Read More »

BLOOD TRANSFUSION | Hemanext Begins Rollout of Hemanext ONE® RBC Processing And Storage System In Europe

Physicians in Norway have initiated recruitment of chronically transfused patients with haematological malignancies, including myelodysplastic syndrome (MDS), to receive transfusions…

Read More »